Skip to main content
. 2021 Oct 1;22(6):816. doi: 10.3892/ol.2021.13077

Figure 2.

Figure 2.

miR-100 expression in breast cancers with different clinical features. (A) hsa-mir-100 expression in the BRCA dataset. (B) hsa-mir-100 expression in BRCA based on individual cancer stages. (C) hsa-mir-100 expression in BRCA based on nodal metastasis status. (D) hsa-mir-100 expression in BRCA based on Menopause status. (E) hsa-mir-100 expression in BRCA based on subclasses. (F) hsa-mir-100 expression in BRCA based on Tumor histology. ****P<0.0001 vs. normal group. miR, microRNA; TCGA, The Cancer Genome Atlas; HER2, human epidermal growth factor receptor 2; TNBC, triple-negative breast cancer; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; INOS, inducible nitric oxide synthase.